Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'oxaliplatin' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 191 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Biasco, G; Gallerani, E
      Treatment of liver metastases from colorectal cancer: what is the best approach today?

      DIGESTIVE AND LIVER DISEASE
    2. Harries, M; Kaye, SB
      Recent advances in the treatment of epithelial ovarian cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    3. Midgley, R; Kerr, D
      Conventional cytotoxic and novel therapeutic concepts in colorectal cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    4. Adam, R; Avisar, E; Ariche, A; Giachetti, S; Azoulay, D; Castaing, D; Kunstlinger, F; Levi, F; Bismuth, F
      Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal [liver] metastases

      ANNALS OF SURGICAL ONCOLOGY
    5. Do, VT; Thomas, GM; Bjarnason, GA
      Postoperative concurrent chronomodulated 5-fluorouracil/leucovorin infusion and pelvic radiotherapy for squamous cell carcinoma of the ovary arising from mature cystic teratoma

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    6. Vermorken, JB
      The integration of paclitaxel and new platinum compounds in the treatment of advanced ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    7. Grothey, A; Schmoll, HJ
      New chemotherapy approaches in colorectal cancer

      CURRENT OPINION IN ONCOLOGY
    8. Launois, R; Portafax, C; Le Lay, K; Megnigbeto, A; Perrocheau, G
      Internet pharmaco-economic studies in metastatic colorectal cancer

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    9. Lu, Y; Mani, S; Kandimalla, ER; Yu, D; Agrawal, S; States, JC; Bregman, DB
      The Cockayne syndrome group B DNA repair protein as an anti-cancer target

      INTERNATIONAL JOURNAL OF ONCOLOGY
    10. Lee, JH; Lee, JH; Kim, TW; Lee, KH; Kang, YK; Lee, JS; Kim, SH; Kim, HC; Yu, CS; Kim, JC; Kim, WK
      Combination of oxaliplatin, fluorouracil, and leucovorin in the treatment of fluoropyrimidine-pretreated patients with metastatic colorectal cancer

      JOURNAL OF KOREAN MEDICAL SCIENCE
    11. Maindrault-Goebel, F; de Gramont, A; Louvet, C; Andre, T; Carola, E; Mabro, M; Artru, P; Gilles, V; Lotz, JP; Izrael, V; Krulik, M
      High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)

      EUROPEAN JOURNAL OF CANCER
    12. Comba, AZ; Blajman, C; Richardet, E; Bella, S; Vilanova, M; Coppola, F; Van Kooten, M; Rodger, J; Giglio, R; Balbiani, L; Perazzo, F; Montiel, M; Chacon, M; Pujol, F; Mickiewicz, E; Cazap, E; Recondo, G; Lastiri, F; Simon, J; Wasserman, E; Schmilovich, A
      A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previouslyuntreated metastatic colorectal cancer patients

      EUROPEAN JOURNAL OF CANCER
    13. Cunningham, D; James, RD
      Integrating the oral fluoropyrimidines into the management of advanced colorectal cancer

      EUROPEAN JOURNAL OF CANCER
    14. Cavaletti, G; Tredici, G; Petruccioli, MG; Donde, E; Tredici, P; Marmiroli, P; Minoia, C; Ronchi, A; Bayssas, M; Etienne, GG
      Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat

      EUROPEAN JOURNAL OF CANCER
    15. Guichard, S; Arnould, S; Hennebelle, I; Bugat, R; Canal, P
      Combination of oxaliplatin and irinotecan on human colon cancer cell lines: activity in vitro and in vivo

      ANTI-CANCER DRUGS
    16. Caponigro, F; Avallone, A; Budillon, A; Comella, P; Comella, G
      Raltitrexed/5-fluorouracil-based combination chemotherapy regimens in anticancer therapy

      ANTI-CANCER DRUGS
    17. Heudi, O; Brisset, H; Cailleux, A; Allain, P
      Chemical instability and methods for measurement of cisplatin adducts formed by interactions with cysteine and glutathione

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    18. Chan, RTT; Au, GKH; Ho, JWC; Chu, KW
      Radiation recall with oxaliplatin: Report of a case and a review of the literture

      CLINICAL ONCOLOGY
    19. Kern, W; Beckert, B; Lang, N; Stemmler, J; Beykirch, M; Stein, J; Goecke, E; Waggershauser, T; Braess, J; Schalhorn, A; Hiddemann, W
      Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer

      ANNALS OF ONCOLOGY
    20. Rosati, G; Rossi, A; Tucci, A; Pizza, C; Manzione, L
      Phase I study of a weekly schedule of oxaliplatin, high-dose leucovorin, and infusional fluorouracil in pretreated patients with advanced colorectal cancer

      ANNALS OF ONCOLOGY
    21. Scheithauer, W; Kornek, GV; Schuell, B; Ulrich-Pur, H; Penz, M; Raderer, M; Lang, F; Schneeweiss, B; Lenauer, A; Depisch, D
      Second-line treatment with oxaliplatin plus raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy

      ANNALS OF ONCOLOGY
    22. Martoni, A; Mini, E; Pinto, C; Nobili, S; Gentile, AL; Dentico, P; Angelelli, B; Scicolone, S; Piana, E; Mazzei, T
      Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma

      ANNALS OF ONCOLOGY
    23. Volk, J; Reinke, F; van Kuilenburg, ABP; van Gennip, AH; Schlichting, C; Ganser, A; Schoffski, P
      Safe administration of irinotecan, oxaliplatin and raltitrexed in a DPD-deficient patient with metastatic colon cancer

      ANNALS OF ONCOLOGY
    24. Garufi, C; Nistico, C; Brienza, S; Vaccaro, A; D'Ottavio, A; Zappala, AR; Aschelter, AM; Terzoli, E
      Single-agent oxaliplatin in pretreated advanced breast cancer patients: A phase II study

      ANNALS OF ONCOLOGY
    25. Bonetti, A; Zaninelli, M; Leone, R; Franceschi, T; Fraccon, AP; Pasini, F; Sabbioni, R; Cetto, GL; Sich, D; Brienza, S; Howell, SB
      Use of the ratio of time to progression following first- and second-line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinoma

      ANNALS OF ONCOLOGY
    26. Grem, JL; Yee, LK; Schuler, B; Hamilton, JM; Chen, AP; Chabuk, C; Grollman, F; Grabenc, M; Allegra, CJ; Takimoto, CH
      N-(phosphonacetyl)-L-aspartate and calcium leucovorin modulation of fluorouracil administered by constant rate and circadian pattern of infusion over72 hours in metastatic gastrointestinal adenocarcinoma

      ANNALS OF ONCOLOGY
    27. Machover, D; Delmas-Marsalet, B; Misra, SC; Gumus, Y; Goldschmidt, E; Schilf, A; Frenoy, N; Emile, JF; Debuire, B; Guettier, C; Farrokhi, P; Boulefdaoui, B; Norol, F; Parquet, N; Ulusakarya, A; Jasmin, C
      Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma

      ANNALS OF ONCOLOGY
    28. Curis, E; Provost, K; Bouvet, D; Nicolis, I; Crauste-Manciet, S; Brossard, D; Benazath, S
      Carboplatin and oxaliplatin decomposition in chloride medium, monitored byXAS.

      JOURNAL OF SYNCHROTRON RADIATION
    29. Haller, DG
      Update on chemotherapy for advanced colorectal cancer

      ONCOLOGY-NEW YORK
    30. Pitot, HC; Goldberg, RM
      Future directions in adjuvant therapy for stage III colon carcinoma

      ONCOLOGY-NEW YORK
    31. Rothenberg, ML; Meropol, NJ; Poplin, EA; Van Cutsem, E; Wadler, S
      Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: Summary findings of an independent panel

      JOURNAL OF CLINICAL ONCOLOGY
    32. Nolte, W; Ramadori, G
      New aspects in the palliative treatment of metastatic colorectal carcinoma

      MEDIZINISCHE KLINIK
    33. Reimer, P; Ruckle-Lanz, H
      New therapeutic options in the chemotherapy of advanced colorectal cancer

      MEDIZINISCHE KLINIK
    34. Louvet, C
      New chemotherapies for colorectal cancer treatment

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    35. Honecker, F; Wedding, U; Kolb, G; Bokemeyer, C
      Chemotherapy in colorectal cancer - Which therapy is justified in elderly patients?

      ONKOLOGIE
    36. Hector, S; Bolanowska-Higdon, W; Zdanowicz, J; Hitt, S; Pendyala, L
      In vitro studies on the mechanisms of oxaliplatin resistance

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    37. Popiela, T; Kulig, J; Hanisch, J; Bock, PR
      Influence of a complementary treatment with oral enzymes on patients with colorectal cancers - an epidemiological retrolective cohort study

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    38. Shields, AF; Lange, M; Zalupski, MM
      Phase II study of liposomal doxorubicin in patients with advanced colorectal cancer

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    39. Stoehlmacher, J; Ghaderi, V; Iqbal, S; Groshen, S; Tsao-Wei, D; Park, D; Lenz, HJ
      A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer

      ANTICANCER RESEARCH
    40. Levi, F; Giacchetti, S; Zidani, R; Brezault-Bonnet, C; Tigaud, JM; Goldwasser, F; Misset, JL
      Chronotherapy of colorectal cancer metastases

      HEPATO-GASTROENTEROLOGY
    41. Verstraete, S; Heudi, O; Cailleux, A; Allain, P
      Comparison of the reactivity of oxaliplatin, Pt(diaminocyclohexane)Cl-2 and Pt(diaminocyclohexane(1))(OH2)(2)(2+) with guanosine and L-methionine

      JOURNAL OF INORGANIC BIOCHEMISTRY
    42. Grivicich, I; Mans, DRA; Peters, GJ; Schwartsmann, G
      Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    43. Falcone, A; Allegrini, G; Masi, G; Lencioni, M; Pfanner, E; Brunetti, I; Danesi, R; Bocci, G; Del Tacca, M; Conte, P
      5-fluorouracil administered as a 48-hour chronomodulated infusion in combination with leucovorin and cisplatin: A randomized phase II study in metastatic colorectal cancer

      ONCOLOGY
    44. Kouroussis, C; Souglakos, J; Kakolyris, S; Mavroudis, D; Malamos, N; Kalbakis, K; Androulakis, N; Agelaki, A; Vardakis, N; Samonis, G; Georgoulias, V
      Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer: A phase II study

      ONCOLOGY
    45. Sargent, DJ; Niedzwiecki, D; O'Connell, MJ; Schilsky, RL
      Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer.

      NEW ENGLAND JOURNAL OF MEDICINE
    46. Pestieau, SR; Belliveau, JF; Griffin, H; Stuart, OA; Sugarbaker, PH
      Pharmacokinetics of intraperitoneal oxaliplatin: Experimental studies

      JOURNAL OF SURGICAL ONCOLOGY
    47. Wei, M; Cohen, SM; Silverman, AP; Lippard, SJ
      Effects of spectator ligands on the specific recognition of intrastrand platinum-DNA cross-links by high mobility group box and TATA-binding proteins

      JOURNAL OF BIOLOGICAL CHEMISTRY
    48. Marchenay, C; Cellarier, E; Levi, F; Rolhion, C; Kwiatkowski, F; Claustrat, B; Madelmont, JC; Chollet, P
      Circadian variation in O-6-alkylguanine-DNA alkyltransferase activity in circulating blood mononuclear cells of healthy human subjects

      INTERNATIONAL JOURNAL OF CANCER
    49. Kubicka, S; Manns, MP
      Additive chemotherapy in liver metastases to improve operability

      CHIRURG
    50. Granda, TG; Filipski, E; D'Attino, RM; Vrignaud, P; Anjo, A; Bissery, MC; Levi, F
      Experimental chronotherapy of mouse mammary adenocarcinoma MA13/C with docetaxel and doxorubicin as single agents and in combination

      CANCER RESEARCH
    51. Scheithauer, W; Kornek, GV; Ulrich-Pur, H; Penz, M; Raderer, M; Salek, T; Haider, K; Kwasny, W; Depisch, D
      Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma - Results of a phase I-II trial

      CANCER
    52. Garufi, G; Dogliotti, L; D'Attino, RM; Tampellini, M; Aschelter, AM; Pugliese, P; Perrone, M; Nistico, C; Comis, S; Terzoli, E
      Irinotecan and chronomodulated infusion of 5-fluorouracil and folinic acidin the treatment of patients with advanced colorectal carcinoma - A phase I study

      CANCER
    53. Laadem, A; Cvitkovic, E
      Oxaliplatin: a first DACH-platinum in oncology

      BULLETIN DU CANCER
    54. Boisdron-Celle, N; Lebouil, A; Allain, P; Gamelin, E
      Pharmacokinetic properties of platinium derivatives

      BULLETIN DU CANCER
    55. Andre, T; Louvet, C; Maindrault-Goebel, F; de Gramont, A
      Oxaliplatin in combination with 5-fluoro-uracil and folinic acid as treatment of metastatic colorectal cancer

      BULLETIN DU CANCER
    56. Raymond, E; Faivre, S; Coudray, AM; Louvet, C; Gespach, C
      Preclinical studies of oxaliplatin in combination chemotherapy

      BULLETIN DU CANCER
    57. Ducreux, N; Fizazi, K; Seitz, JF; Becouarn, Y; Armand, JP
      Oxaliplatin in combination with non fluoropyrimidine drugs in colorectal cancer

      BULLETIN DU CANCER
    58. Goldwasser, F; Misset, JL
      Clinical use of oxaliplatin in solid tumors

      BULLETIN DU CANCER
    59. Bugat, R
      Oxaliplatin: safety profile in metastatic colorectal cancer

      BULLETIN DU CANCER
    60. Chau, I; Webb, A; Cunningham, D; Hill, M; Waters, JS; Norman, A; Massey, A
      Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer

      BRITISH JOURNAL OF CANCER
    61. McKeage, MJ; Hsu, T; Screnci, D; Haddad, G; Baguley, BC
      Nucleolar damage correlates with neurotoxicity induced by different platinum drugs

      BRITISH JOURNAL OF CANCER
    62. Sobrero, A; Guglielmi, A; Cirillo, M; Recaldin, E; Frassineti, GL; Aschele, C; Ravaioli, A; Testore, P; Caroti, C; Gallo, L; Pessi, MA; Cortesi, E; Turci, D; Grossi, F; Labianca, R
      5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highlyeffective, low cost chemotherapy for advanced colorectal cancer

      BRITISH JOURNAL OF CANCER
    63. Fischel, JL; Rostagno, P; Formento, P; Dubreuil, A; Etienne, MC; Milano, G
      Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines

      BRITISH JOURNAL OF CANCER
    64. Belliveau, J; Griffin, H
      The solubility of calcium oxalate in tissue culture media

      ANALYTICAL BIOCHEMISTRY
    65. Norum, J
      Oxaliplatin in colorectal cancer patients living in an arctic or subarcticarea: Significant cold-triggered dysesthesias and laryngeal reactions

      JOURNAL OF CHEMOTHERAPY
    66. MacLean, DS; Khokhar, AR; Perez-Soler, R
      Neutron activation of NDDP, a liposomal platinum antitumor agent

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    67. Mormont, MC; Waterhouse, J; Bleuzen, P; Giacchetti, S; Jami, A; Bogdan, A; Lellouch, J; Misset, JL; Touitou, Y; Levi, F
      Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status

      CLINICAL CANCER RESEARCH
    68. Bible, KC; Boerner, SA; Kirkland, K; Anderl, KL; Bartelt, D; Svingen, PA; Kottke, TJ; Lee, YK; Eckdahl, S; Stalboerger, PG; Jenkins, RB; Kaufmann, SH
      Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridol

      CLINICAL CANCER RESEARCH
    69. Sobrero, A; Kerr, D; Glimelius, B; Van Cutsem, E; Milano, G; Pritchard, DM; Rougier, P; Aapro, M
      New directions in the treatment of colorectal cancer: a look to the future

      EUROPEAN JOURNAL OF CANCER
    70. Focan, C; Kreutz, F; Focan-Henrard, D; Moeneclaey, N
      Chronotherapy with 5-fluorouracil, folinic acid and carboplatin for metastatic colorectal cancer; an interesting therapeutic index in a phase II trial

      EUROPEAN JOURNAL OF CANCER
    71. Fizazi, K; Caliandro, R; Soulie, P; Fandi, A; Daniel, C; Bedin, A; Doubre, H; Viala, J; Rodier, JM; Trandafir, L; Le Chevalier, T; Cvitkovic, E; Armand, JP; Ruffie, P
      Combination raltitrexed (Tomudex (R))-oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma

      EUROPEAN JOURNAL OF CANCER
    72. Hejna, M; Kostler, WJ; Raderer, M; Tomek, S; Brodowicz, T; Scheithauer, W; Wiltschke, C; Zielinski, CC
      Phase II study of second-line oxaliplatin, irinotecan and mitomycin C in patients with advanced or metastatic colorectal cancer

      ANTI-CANCER DRUGS
    73. Louvet, C; Coudray, AM; Tournigand, C; Prevost, S; Raymond, E; de Gramont, A; Chazard, M; Gespach, C
      Synergistic antitumoral activity of combined UFT, folinic acid and oxaliplatin against human colorectal HT29 cell xenografts in athymic nude mice

      ANTI-CANCER DRUGS
    74. Garufi, C; Brienza, S; Pugliese, P; Aschelter, AM; Bensmaine, MA; Bertheault-Cvitkovic, F; Nistico, C; Giunta, S; Caterino, M; Giannarelli, D; Cosimelli, M; Levi, F; Terzoli, E
      Overcoming resistance to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancerpatients

      ANTI-CANCER DRUGS
    75. Gornet, JM; Azoulay, D; Levi, F; Yovine, A; Misset, JL; Goldwasser, F
      Dramatic tumor response of bulky liver metastases following treatment withCPT-11 and a chronomodulated 4-day infusion of 5-fluorouracil, folinic acid and oxaliplatin every 2 weeks in a colorectal cancer patient

      ANTI-CANCER DRUGS
    76. Mohammed, MQ; Retsas, S
      Oxaliplatin is active in vitro against human melanoma cell lines: comparison with cisplatin and carboplatin

      ANTI-CANCER DRUGS
    77. Comella, P; De Vita, F; De Lucia, L; Casaretti, R; Avallone, A; Orditura, M; Rivellini, F; Palmeri, S; Catalano, G; Comella, G
      Oxaliplatin and raltitrexed combined with leucovorin-modulated 5-fluorouracil i.v. bolus every two weeks: A dose finding study in advanced previouslytreated colorectal carcinoma

      ANNALS OF ONCOLOGY
    78. Janinis, J; Papakostas, P; Samelis, G; Skarlos, D; Papagianopoulos, P; Fountzilas, G
      Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: A Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study

      ANNALS OF ONCOLOGY
    79. Sobrero, A; Zaniboni, A; Frassineti, GL; Aschele, C; Guglielmi, A; Giuliani, R; Ravaioli, A; Lanfranco, C; Caroti, C; Arnoldi, E; Barni, S; Gallo, L; Pessi, MA; Turci, D; Cortesi, E; Grossi, F; Frontini, L; Piazza, E; Bruzzi, P; Labianca, R
      Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: A randomized study

      ANNALS OF ONCOLOGY
    80. Goldwasser, F; Gross-Goupil, M; Tigaud, JM; Di Palma, M; Marceau-Suissa, J; Wasserman, E; Yovine, A; Misset, JL; Cvitkovic, E
      Dose escalation of CPT-11 in combination with oxaliplatin using an every two weeks schedule: A phase I study in advanced gastrointestinal cancer patients

      ANNALS OF ONCOLOGY
    81. Maindrault-Goebel, F; de Gramont, A; Louvet, C; Andre, T; Carola, E; Gilles, V; Lotz, JP; Tournigand, C; Mabro, M; Molitor, JL; Artru, P; Izrael, V; Krulik, M
      Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer

      ANNALS OF ONCOLOGY
    82. Royce, ME; Medgyesy, D; Zukowski, TH; Dwivedy, S; Hoff, PM; Pazdur, R
      Colorectal cancer: Chemotherapy treatment overview

      ONCOLOGY-NEW YORK
    83. Berlin, J
      Second-line therapy in colorectal cancer

      ONCOLOGY-NEW YORK
    84. Hoff, PM
      Novel therapeutic approaches for metastatic colorectal cancer

      ONCOLOGY-NEW YORK
    85. Paule, B; Brion, N
      Advanced colorectal cancer: new chemotherapeutic agents

      PRESSE MEDICALE
    86. Napier, MP; Ledermann, JA
      Novel chemotherapeutic agents in colorectal cancer

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    87. Morrison, JG; White, P; McDougall, S; Firth, JW; Woolfrey, SG; Graham, MA; Greenslade, D
      Validation of a highly sensitive ICP-MS method for the determination of platinum in biofluids: application to clinical pharmacokinetic studies with oxaliplatin

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    88. Baur, M; Kienzer, HR; Rath, T; Dittrich, C
      Extravasation of oxaliplatin (Eloxatin (R)) - clinical course

      ONKOLOGIE
    89. Massari, C; Brienza, S; Rotarski, M; Gastiaburu, J; Misset, JL; Cupissol, D; Alafaci, E; Dutertre-Catella, H; Bastian, G
      Pharmacokinetics of oxaliplatin in patients with normal versus impaired renal function

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    90. Mosconi, S; Cascinu, S; Zaniboni, A; Catalano, V; Giordani, P; Beretta, GD; Martignoni, G; Pancera, G; Baldelli, AM; Poletti, P; Curti, C; Labianca, R
      The value of oxaliplatin in combination with continuous infusion +/- bolus5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: A GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trial

      TUMORI
    91. Marchetti, P; Galla, DAP; Cifone, G; Ricevuto, E; Ficorella, C
      Action mechanisms and pharmacology of new active organometal compounds in the treatment of colorectal cancer

      TUMORI
    92. Gebbia, N; Martello, A; Bajardi, E
      Preclinical aspects of new molecules acting against colorectal neoplasias

      TUMORI
    93. Bonetti, A
      New treatment approaches for advanced colorectal cancer

      TUMORI
    94. Dogliotti, L; Garufi, C; Iacobelli, S
      Chronochemotherapy

      TUMORI
    95. Cartei, G
      New options for patients previously treated for metastatic colon cancer - platinum salts

      TUMORI
    96. Cascinu, S; Munao, S; Mare, M; Amadio, P; Crucitta, E; Picone, G
      Tolerance profiles of platinum coordination compounds

      TUMORI
    97. Delaloge, S; Laadem, A; Taamma, A; Chouaki, N; Cvitkovic, E; Pautier, P; Misset, JL; Lhomme, C
      Pilot study of the paclitaxel, oxaliplatin, and cisplatin combination in patients with advanced/recurrent ovarian cancer

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    98. Chaouche, M; Pasturaud, AL; Kamioner, D; Grandjean, M; Franiatte, J; Tourani, JM
      Oxaliplatin, 5-fluorouracil, and folinic acid (Folfox) in patients with metastatic renal cell carcinoma - Results of a pilot study

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    99. Maclean, DS; Khokhar, AR; Tyle, P; Perez-Soler, R
      Intraliposomal chemical activation patterns of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) (L-NDDP) - a potential antitumour agent

      JOURNAL OF MICROENCAPSULATION
    100. Kern, W; Beckert, B; Lang, N; Waggershauser, T; Braess, J; Schalhorn, A; Hiddemann, W
      Hepatic arterial infusion with oxaliplatin, folinic acid, and 5-fluorouracil in patients with hepatic metastases from colorectal cancer: Role of carcino-embryonic antigen in assessment of response

      ANTICANCER RESEARCH


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 01:36:10